Back to search
FDAFDA · Food and drugs·Recall number D-0118-2024

ELCYS (cysteine hydrochloride injection), USP, 500 mg/10mL (50 mg/mL), 10x10 mL Single Dose Sterile Vials, For Intravenous Infusion Only, Rx Only, Manufactured and Distributed by Exela Pharma Sciences, LLC, Lenoir, NC 28645, (Vial: NDC 51754-1007-1; Carton: 51754-1007-3).

Published November 29, 2023 · Recall initiated: October 18, 2023

Summary

FDA records drug Class I recall D-0118-2024, published November 29, 2023 and initiated October 18, 2023. Recalling firm: Exela Pharma Sciences LLC; Status: Ongoing; Reported quantity: 38,200 vials; Lot: Lot # 10000798, Expiration Date 03/31/2025. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Silicone

What to do

Voluntary: Firm initiated · Letter

Get an email if ELCYS has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ELCYS
Manufacturer
Exela Pharma Sciences LLC
Distributor
Nationwide
Lot
Lot # 10000798, Expiration Date 03/31/2025
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was ELCYS (cysteine hydrochloride injection), USP, 500 mg/10mL (50 mg/mL), 10x10 mL Single Dose Sterile Vials, For Intravenous Infusion Only, Rx Only, Manufactured and Distributed by Exela Pharma Sciences, LLC, Lenoir, NC 28645, (Vial: NDC 51754-1007-1; Carton: 51754-1007-3). recalled?

Yes. FDA published recall D-0118-2024 on November 29, 2023. Reported hazard: Presence of Particulate Matter: Silicone

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ELCYS.